Skip to main content

Acute pancreatitis and refractory hypercalcemia in the third trimester caused by parathyroid carcinoma

Abstract

Background

Hypercalcemia can be a rare contributor to acute pancreatitis (AP) in pregnancy. This is primarily due to primary hyperparathyroidism (PHPT), resulting from parathyroid carcinoma. We exhibited a case report to analyze the diagnosis and treatment during the onset of hypercalcemia-induced AP.

Case presentation

A 32-year-old primigravida presented with acute pancreatitis near full-term gestation. Following a cesarean delivery, there was a reduction in serum amylase and peripancreatic exudate, but her serum calcium concentrations persistently elevated over 4.0 mmol/L. Interventions to lower the hypercalcemia were only temporarily effective, until a high serum parathyroid hormone (PTH) concentration of 1404 pg/mL was detected. Ultrasound revealed a 31 mm × 24 mm hypoechoic oval nodule in the left lower lobe of the thyroid gland. She underwent a parathyroidectomy, resulting in a dramatic decrease in serum PTH level, from preoperative levels of 2051 pg/mL to 299 pg/mL just 20 minutes after removal. Similarly, her serum calcium declined from 3.82 mmol/L to 1.73 mmol/L within 24 hours postoperatively. The final histopathology suggested parathyroid carcinoma.

Conclusion

When refractory hypercalcemia is present, serum PTH levels should be measured to determine PHPT. Parathyroidectomy is the optimal strategy for alleviating hypercalcemia and clarifying the underlying pathology.

Peer Review reports

Introduction

Acute pancreatitis (AP) in pregnancy due to hypercalcemia is uncommon [1]. The mechanisms underlying hypercalcemia-induced AP involve the deposition of calcium in the pancreatic duct and the activation of trypsinogen within the pancreatic parenchyma [2, 3]. Primary hyperparathyroidism (PHPT) is the most frequent causes of hypercalcemia, accounting for more than 90% of all instances [4]. Long-standing overproduction of parathyroid hormone (PTH) and hypercalcemia can lead to progressive damage to vital organs and even mortality [5, 6]. This report presents a sporadic case of AP resulting from parathyroid carcinoma, occurring during near-term gestations. The objective is to enhance the differential diagnosis of parathyroid carcinoma by elucidating the diagnostic and therapeutic procedures employed for this condition.

Case presentation

A 32-year-old primigravida at 36+ 3 weeks gestation presented to the emergency department with acute epigastric pain persisting for two days, accompanied by abdominal distension and nausea. Upon the reception, her blood pressure was measured at 135/87 mmHg. Laboratory investigations revealed elevated serum amylase levels of 935U/L (normal range 35–135) and serum creatine of 110µmol/L (normal range 64–104). Abdominal ultrasound confirmed the diagnosis of acute pancreatitis by revealing an edematous pancreas (Fig. 1A). Following admission, an urgent cesarean section was performed, resulting in the successful delivery of a live birth weighting 2470 g with an Apgar score of 10-10-10. The expulsion of the placenta and membranes was complete.

After the cesarean delivery, the patient’s amylase rose to 1501 U/L, and serum calcium concentrations were alarmingly high at 4.06 mmol/L (normal range 2.20–2.55). Due to the severity of conditions, she was transferred to the intensive care unit for further treatment. Although the serum amylase exhibited a stepwise decrease, severe hypercalcemia (over 4.0mmol/L) persisted. Attempts to lower the hypercalcemia with calcitonin and dialysis only provided temporary relief, as serum calcium levels rebounded within one day. Further laboratory investigations found an abnormally high serum PTH concentration of 1404 pg/mL (normal range 10–65). On the fourth postoperative day, ultrasound revealed a 31 mm × 24 mm hypoechoic oval nodule in the left lower lobe of the thyroid gland—suggestive of a parathyroid adenoma (Fig. 1B). A fine needle aspiration (FNA) was performed by an otolaryngologist, and confirmed the tissue as the source of the parathyroid. Immunohistochemistry: CgA(+), CT(-), Cyclin D1(-), Ki-67(< 1%), Syn(-), TTF-1(-). Meanwhile, a contrast-enhanced magnetic resonance imaging (MRI) of the neck soft tissues supported the diagnosis of parathyroid adenoma. After a week of treatment, the serum amylase decreased, and CT images demonstrated a reduction in peripancreatic exudate. Based on a multidisciplinary discussion, the otolaryngologists decided to perform a resection of the left parathyroid adenoma. Serum PTH concentrations dramatically decreased from preoperative levels of 2051 pg/mL to 299 pg/mL at 20 min after the removal of tumor tissue. Serum calcium remained at a concentration of 3.82 mmol/L after the patient returned to the ward, dropped to 1.73 mmol/L within 24 hours postoperatively. Histopathology revealed features of angioinvasion, and immunohistochemical staining exhibited a Ki67 labeling index of 5% (Fig. 1C-D). A PET-CT scan did not reveal any hypermetabolic malignant lesions elsewhere but did identify gallbladder stones, multiple nephrolithiasis, multiple bilateral anterior rib fractures, and systemic osteoporosis. Following the histopathological evaluation confirming parathyroid carcinoma, a remedial surgery including ipsilateral thyroid excision and lymph node dissection was performed. Both intraoperative frozen section analysis and subsequent pathological reports confirmed the presence of a nodular goiter. The patient received intravenous calcium infusion (calcium gluconate 1–2 g/d) combined with oral route postoperatively, until serum calcium levels stabilized. Due to their susceptibility to the hungry bone syndrome after removal of a parathyroid tumor, she was prescribed oral calcium, vitamin D, and osteotriol for three months post-discharge. She has maintained normal serum parathyroid and calcium levels in recent two years.

Fig. 1
figure 1

Imaging and pathological findings. (A) On Day 1 following admission, CT showed an edematous pancreas. (B) A hypoechoic oval nodule with a size of 31 mm × 24 mm in the left lower lobe of the thyroid gland. (C)–(D) Pathology of parathyroid carcinoma. (C) Parathyroid gland section profile. (D) Hematoxylin-eosin staining (×200): tumor cells invaded the capsule and blood vessels

Discussion

Acute pancreatitis (AP) during pregnancy can arise from a variety of factors, and PHPT is a less common etiology [1, 7]. It has been reported that the prevalence of AP was 6.0%-8.0% among PHPT patients, much higher than that of the general population [8, 9]. Moreover, the PHPT-related AP is more commonly reported in the third trimester (50%) and the second trimester (34.6%) [10]. Parathyroid carcinoma, a rare cause of PHPT, affecting less than 1% of PHPT patients [11]. Based on the published literatures, there were 18 cases of AP due to parathyroid carcinoma, with only two occurring in pregnant women [9, 10, 12,13,14,15,16]. Distinguishing between parathyroid carcinoma and benign adenoma demonstrates a challenge regardless of clinical symptoms and pathological diagnosis. Generally, parathyroid carcinoma is more frequently characterized by renal involvement (56-84% accompanied by nephrolithiasis), high serum calcium levels (>3.5mmol/L), and a significant increase in PTH concentration (exceeding 10 times the upper limit of the reference value) [17,18,19]. This case was initially thought to be parathyroid adenoma based on the preoperative image screening, leading to a local resection in the first surgery. FNA of tissue was performed and the result needed three days to return. Alternatively, suspected parathyroid tissue can be diluted with saline up to 2 mL and sent for biochemical analysis of PTH [20]. The result will yield within 2 hours. That may be a new way to fast diagnosis. Notably, the patient had undergone cystoscopy two years ago to remove the left ureteral calculi for multiple nephrolithiasis. Her postoperative serum calcium concentration was 3.08mmol/L at that time, but no further examination was conducted. There is no updated data on her serum calcium levels until the onset of AP. She did not receive regular calcium supplements during this pregnancy, possibly due to the known hypercalcemia and nephrolithiasis. The neonatal birth weight, although slightly lower than average, is within normal limits for a baby born at 36+ 3 weeks. Figure 2 illustrates the relationship between hyperparathyroidism-dependent hypercalcemia and PTH levels. Serum calcium levels seemed to fluctuate by the PTH curve. PTH stimulates the hydroxylation of 25-OHD, leading to elevated calcitriol levels, which contribute to hypercalciuria and multiple calculus formation [11]. The optimal treatment strategy of parathyroid carcinoma is parathyroidectomy, while the necessity of additional thyroid lobectomy remains debatable [21, 22]. Given that approximately two-thirds of individuals exhibit lymph node or distant metastases at their first presentation, a PET-CT scan was performed [23]. The scan revealed systemic osteoporosis and multi-site calculi, findings not typical for her age. To mitigate the risks associated with a rapid decrease in serum calcium levels, including hypocalcemic symptoms and life-threatening complications, routine calcium supplementation post-parathyroidectomy is essential. Oral calcium supplementation is preferred during rehabilitation, with intravenous calcium infusion as an alternative when necessary. Long-term postoperative follow-ups are crucial for tracking recurrence and metastasis.

Fig. 2
figure 2

The changes of laboratory indexes before and after treatment

In conclusion, this detailed report highlighted a rare case of parathyroid carcinoma-associated pancreatitis in pregnant woman. In this case, prompt diagnosis and urgent delivery via cesarean section were crucial in mitigating potential harm to both the mother and fetus. The key breakthrough was identifying maternal refractory hypercalcemia. It is, therefore, essential to determine serum PTH levels to evaluate the impact of PHPT when persistent hypercalcemia is detected. Surgical interventions are the optimal way to improve prognoses.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Mądro A. Pancreatitis in pregnancy-comprehensive Review[J]. Int J Environ Res Public Health,2022,19(23).

  2. Carnaille B, Oudar C, Pattou F, Combemale F, Rocha J, Proye C. Pancreatitis and primary hyperparathyroidism: forty cases[J]. Aust N Z J Surg. 1998;68(2):117–9.

    Article  CAS  PubMed  Google Scholar 

  3. Bai HX, Giefer M, Patel M, Orabi AI, Husain SZ. The association of primary hyperparathyroidism with pancreatitis[J]. J Clin Gastroenterol. 2012;46(8):656–61.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Dandurand K, Ali DS, Khan AA. Hypercalcemia in Pregnancy[J]. Endocrinol Metab Clin North Am 2021,50(4):753–68.

  5. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O’Fallon WM, et al. Survival after the diagnosis of hyperparathyroidism: a population-based study[J]. Am J Med. 1998;104(2):115–22.

    Article  CAS  PubMed  Google Scholar 

  6. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience[J]. Head Neck. 2004;26(8):716–26.

    Article  PubMed  Google Scholar 

  7. Haiyan Z, Na P, Jialin H, Qingjian L, Jianying B, Xiumei B. Acute pancreatitis in pregnancy: a ten-year noninterventional, retrospective cohort Experience[J]. Gastroenterol Res Pract,2022,2022:3663079.

  8. Misgar RA, Bhat MH, Rather TA, Masoodi SR, Wani AI, Bashir MI et al. Primary hyperparathyroidism and pancreatitis[J]. J Endocrinol Invest 2020,43(10):1493–8.

  9. Devgan Y, Mayilvaganan S, Mishra A, Chand G, Agarwal G, Mohindra S et al. PHPT with pancreatitis: atypical presentation of PHPT[J]. Indian J Endocrinol Metab 2023,27(6):513–8.

  10. Zhou Y, Wang Q, Zou L, Wu X, Yang A. Parathyroid carcinoma-related severe acute pancreatitis during pregnancy: a case report and literature review[J]. Gastroenterol Rep (Oxf),2023,11:c87.

  11. Marx SJ. Hyperparathyroid and hypoparathyroid disorders[J]. N Engl J Med. 2000;343(25):1863–75.

    Article  CAS  PubMed  Google Scholar 

  12. Toyoda M, Suganuma N, Takahashi A, Masuda T, Goda M, Yoshida T et al. Parathyroid carcinoma with pancreatitis causing hypercalcaemic emergency treated with extracorporeal membrane oxygenation-assisted parathyroid resection[J]. Endocrinol Diabetes Metab Case Rep,2023,2023(1).

  13. Zelano L, Locantore P, Rota CA, Policola C, Corsello A, Rossi ED et al. Parathyroid carcinoma All-In-One, a Rare Life-threatening case with multiple systemic manifestations: Case Report and Review of the Literature[J]. Front Endocrinol (Lausanne),2022,13:881225.

  14. Mignini I, Pizzoferrato M, Larosa L, Gasbarrini A, Rapaccini GL, Armuzzi A. Acute pancreatitis and parathyroid carcinoma: a case report and literature review[J]. Eur Rev Med Pharmacol Sci 2021,25(19):5972–7.

  15. Imam Z, Hanna A, Jomaa D, Khasawneh M, Abonofal A, Murad MH. Hypercalcemia Malignancy Acute Pancreatitis[J] Pancreas 2021,50(2):206–13.

  16. Jiajue R, Song A, Wang O, Li W. Persistent Hypercalcemia Crisis and recurrent Acute Pancreatitis due to multiple ectopic parathyroid carcinomas: Case Report and Literature Review of Mediastinal parathyroid Carcinoma[J]. Front Endocrinol (Lausanne),2020,11:647.

  17. Givi B, Shah JP. Parathyroid carcinoma[J]. Clin Oncol (R Coll Radiol),2010,22(6):498–507.

  18. Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ. Overview of the 2022 WHO classification of parathyroid Tumors[J]. Endocr Pathol 2022,33(1):64–89.

  19. Schaapveld M, Jorna FH, Aben KK, Haak HR, Plukker JT, Links TP. Incidence and prognosis of parathyroid gland carcinoma: a population-based study in the Netherlands estimating the preoperative diagnosis[J]. Am J Surg. 2011;202(5):590–7.

    Article  PubMed  Google Scholar 

  20. Sabbah N, Demar M, Sogbo F, Zappa M, Alsibai KD, Amroun H et al. Recurrent vomiting and confusion in pregnancy: hypercalcaemia due to parathyroid adenoma[J]. Lancet 2023,402(10395):62–3.

  21. Kong SH, Kim JH, Park MY, Kim SW, Shin CS. Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort[J]. J Cancer Res Clin Oncol 2021,147(10):3091–7.

  22. Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E et al. Parathyroid carcinoma: a 43-year outcome and survival analysis[J]. J Clin Endocrinol Metab 2011,96(12):3679–86.

  23. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients[J]. Med (Baltimore) 1992,71(4):197–205.

Download references

Acknowledgements

I would particularly like to acknowledge my colleagues from the paramedical departments, for selflessly providing the raw CT/ultrasound/pathology image materials.

Funding

Guangzhou fundamental research project jointly funded by School (Institution) (high-level university) No. 202102010131.

Author information

Authors and Affiliations

Authors

Contributions

Put forward the original idea: F He. Wrote the manuscript and prepared Figs. 1 and 2: QW Nie, SL OY. Revised and polished the content: F He, QW Nie, SL OY.

Corresponding author

Correspondence to Fang He.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent for publication was obtained from the patient.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nie, Q., Ouyang, S. & He, F. Acute pancreatitis and refractory hypercalcemia in the third trimester caused by parathyroid carcinoma. BMC Pregnancy Childbirth 24, 483 (2024). https://doi.org/10.1186/s12884-024-06636-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12884-024-06636-3

Keywords